علاج تسرع القلب البطيني متعدد الأشكال الكاتيكولاميني في الحامل الجيني الإيجابي بدون أعراض

References

DOI: 10.1093/eurheartj/ehac262

1. It is recommended that CPVT is diagnosed in patients who are carriers of a mutation in disease-causing genes.
2. This panel has confirmed the indication to treat genetically positive family members with beta-blockers, even in the absence of documented exercise- or stress-induced VAs.
3. Therapy with beta-blockers should be considered for genetically positive CPVT patients without phenotype.
4. Avoidance of competitive sports, strenuous exercise, and exposure to stressful environments is recommended in all patients with CPVT.
5. Non-selective beta-blockers such as nadolol and propranolol are preferred.